Debate: Is there an optimal treatment for refractory colorectal cancer? - Immunotherapy
Debate: Is there an optimal treatment for refractory colorectal cancer? - TAS-102 or regorafenib
Debate: Optimal salvage therapy for refractory colon cancer? - Immunotherapy
Debate: Optimal salvage therapy for refractory colon cancer? - TAS102 or Regorafenib
Selecting the optimal first-line treatment in advanced colorectal cancer
Goals of Therapy in Refractory Colorectal Cancer
Debate: Is there an optimal sequence for first-line therapy in mCRC? - Yes
Chemorefractory Colorectal Cancer
Patient Perspective: Rectal Cancer - The Treatment
Treatment Goals in Refractory mCRC
Sequencing Decisions in Relapsed/Refractory Colorectal Cancer
When You Have Decided to Prescribe Trifluridine/Tipiracil
Optimal Dosing of Regorafenib in Colorectal Cancer
Debate: Salvage therapy for mCRC? Regorafenib followed by TAS-102
Final Thoughts on the Treatment of Metastatic Colorectal Cancer
Controversy Debate 4: Treatment algorithms in metastatic CRC - ESMO guidelines
Third-Line Therapy for Metastatic Colorectal Cancer
Prof Tim Price on refractory colorectal cancer (Part 2)
Novel Agents and Targets in Colorectal Cancer
Colorectal Cancer | Practical Perspectives: Investigators Discuss Current Management and Actual C...